Medical Device News Magazine

HOYA Vision Care Announces New Sensity® 2 Light-Adaptive Lenses with Nearly Twice the Fadeback Speed

Advanced lens technology offers nearly twice the fadeback speed of its first generation Demand for light-adaptive lenses increases as two-thirds of patients now report sensitivity

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Ophthalmic lens technology leader HOYA Vision Care announced today the next generation of its popular Sensity light-adaptive lenses. Two out of every three eyecare patients experience light sensitivity, making light-adaptive lenses a convenient and comfortable everyday vision solution for most patients.

A significant improvement compared to the previous generation of Sensity lenses, Sensity 2 lenses offer nearly twice the fadeback speed – approximately 42 percent faster.

Building on more than five years of success with its first-generation Sensity® lenses, HOYA Vision Care has created a product that rapidly darkens to a category 3 sun lens tint, fades back nearly twice as fast to a clear lens indoors, and still offers the same comfort, convenience, and protection as the entire Sensity family – with 100% UV protection, reduced glare from the sun when activated, and blue light protection indoors and outdoors2.

Available today, Sensity 2 lenses come in three intense natural color options: Silver Grey, Bronze Brown, and Emerald Green. They are compatible with HOYA’s Single Vision, Backside Progressives, and iD designs, as well as all of HOYA’s current antireflective treatments.

Two key technological innovations underlie the improved performance of the lenses: Stabilight Technology provides consistent performance and UV protection no matter the climate, cold or warm. Precision Technology ensures a microscopically accurate spin-coating process, creating superior adhesion for great scratch resistance.

“We are excited to bring Sensity 2 lenses to the market, offering an even faster fadeback that ECPs and their patients will greatly benefit from,” said Nick LaManna, Director of Product Management for HOYA Vision Care, North America. “Our continuous focus on improving our products has made us an industry leader in light-adaptive lens technology, and these are no exception.”

Interested ECPs can ask their HOYA Territory Sales Manager for more information about Sensity 2 light-adaptive lenses. Additionally, Visionary Alliance members are eligible to earn points when they choose Sensity 2 for their patients’ vision needs.


1. Harris Interactive Consumer Market Research Study, Global Report, Nov 2019: Usage Behavior When Outdoors

2. Based on internal testing of average light transmission between 381nm-500nm compared to standard clear lens

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”